Titan Pharmaceuticals, Inc. is a pharmaceutical company. Co. is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix implant that is placed subdermally, normally in the inside part of the upper arm, in a brief procedure using a local anesthetic and is removed in a similar manner at the end of the treatment period. We show 43 historical shares outstanding datapoints in our coverage of TTNP's shares outstanding history.
Understanding the changing numbers of TTNP shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like TTNP versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching TTNP by allowing them to research TTNP shares outstanding history
as well as any other stock in our coverage universe. |
Free TTNP Email Alerts:
Video: Shares Outstanding Importance
